TY - JOUR
T1 - Dinámica mitocondrial
T2 - un potencial nuevo blanco terapéutico para la insuficiencia cardiaca
AU - Kuzmicic, Jovan
AU - Del Campo, Andrea
AU - López-Crisosto, Camila
AU - Morales, Pablo E.
AU - Pennanen, Christian
AU - Bravo-Sagua, Roberto
AU - Hechenleitner, Jonathan
AU - Zepeda, Ramiro
AU - Castro, Pablo F.
AU - Verdejo, Hugo E.
AU - Parra, Valentina
AU - Chiong, Mario
AU - Lavandero, Sergio
PY - 2011/10
Y1 - 2011/10
N2 - Mitochondria are dynamic organelles able to vary their morphology between elongated interconnected mitochondrial networks and fragmented disconnected arrays, through events of mitochondrial fusion and fission, respectively. These events allow the transmission of signaling messengers and exchange of metabolites within the cell. They have also been implicated in a variety of biological processes including embryonic development, metabolism, apoptosis, and autophagy. Although the majority of these studies have been confined to noncardiac cells, emerging evidence suggests that changes in mitochondrial morphology could participate in cardiac development, the response to ischemia-reperfusion injury, heart failure, and diabetes mellitus. In this article, we review how the mitochondrial dynamics are altered in different cardiac pathologies, with special emphasis on heart failure, and how this knowledge may provide new therapeutic targets for treating cardiovascular diseases.
AB - Mitochondria are dynamic organelles able to vary their morphology between elongated interconnected mitochondrial networks and fragmented disconnected arrays, through events of mitochondrial fusion and fission, respectively. These events allow the transmission of signaling messengers and exchange of metabolites within the cell. They have also been implicated in a variety of biological processes including embryonic development, metabolism, apoptosis, and autophagy. Although the majority of these studies have been confined to noncardiac cells, emerging evidence suggests that changes in mitochondrial morphology could participate in cardiac development, the response to ischemia-reperfusion injury, heart failure, and diabetes mellitus. In this article, we review how the mitochondrial dynamics are altered in different cardiac pathologies, with special emphasis on heart failure, and how this knowledge may provide new therapeutic targets for treating cardiovascular diseases.
UR - http://www.scopus.com/inward/record.url?scp=80052966447&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052966447&partnerID=8YFLogxK
U2 - 10.1016/j.recesp.2011.05.018
DO - 10.1016/j.recesp.2011.05.018
M3 - Estudio breve
C2 - 21820793
AN - SCOPUS:80052966447
SN - 0300-8932
VL - 64
SP - 916
EP - 923
JO - Revista Espanola de Cardiologia
JF - Revista Espanola de Cardiologia
IS - 10
ER -